ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $766,081 | -11.9% | 28,227 | -0.2% | 0.01% | -7.7% |
| Q2 2023 | $869,665 | -14.7% | 28,291 | 0.0% | 0.01% | -27.8% |
| Q1 2023 | $1,019,325 | +17.7% | 28,291 | +29.1% | 0.02% | 0.0% |
| Q4 2022 | $866,041 | -1.7% | 21,914 | 0.0% | 0.02% | -10.0% |
| Q3 2022 | $881,000 | +8.9% | 21,914 | +13.8% | 0.02% | +5.3% |
| Q2 2022 | $809,000 | +7.9% | 19,249 | 0.0% | 0.02% | +18.8% |
| Q1 2022 | $750,000 | -2.2% | 19,249 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $767,000 | +164.5% | 19,249 | +139.6% | 0.02% | +128.6% |
| Q3 2021 | $290,000 | -12.4% | 8,033 | -0.7% | 0.01% | -12.5% |
| Q2 2021 | $331,000 | -6.0% | 8,087 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $352,000 | +10.7% | 8,087 | +27.2% | 0.01% | 0.0% |
| Q4 2020 | $318,000 | – | 6,356 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |